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Abstract
Purpose: To assess the efficacy and safety of a new rota-
tional catheter for percutaneous removal of fresh and or-
ganized thrombi in the femoropopliteal artery.
Methods: Forty-one limbs in 38 patients (age 56–90 years,
mean 75.6 years) with acute, subacute or chronic femoro-
popliteal occlusions of 1–180 days duration (mean 31.6
days) were treated with the Rotarex device. The Fontaine
stage was mainly IIB (Rutherford 2–3, 22 patients) or III
(Rutherford 4, 14 patients). The length of occlusion varied
from 2 to 35 cm (mean 13.1 cm). After recanalization per-
cutaneous transluminal angioplasty (PTA) was performed if
there was a residual stenosis of >25%. Patients were fol-
lowed up with color Doppler ultrasound at 48 hr and clin-
ically with Doppler pressures and oscillometry at 3, 6, and
12 months.
Results: After an average of two passages with the Rotarex
catheter all but two limbs required PTA for residual stenosis
>25%. Five patients needed additional stenting. Major
complications were one groin hematoma requiring blood
transfusion and one arteriovenous fistula spontaneously
thrombosing after unsuccessful primary prolonged balloon
dilation. Distal embolizations occurred in 10 patients; 6
clinically relevant emboli were aspirated. All occlusions
were technically successfully recanalised there were 2 early
reocclusions after 1 day and two at 2 weeks. Brachial–ankle
indices improved from an average of 0.41 before to 0.93
after recanalization. Primary and secondary patency rates
were 62% / 84% after 6 months and 39% / 68% after 1
year. The amputation-free survival at 12 months was 100%.
Conclusion: The Rotarex mechanical thrombectomy device
is an efficient, quick, easy to handle, and safe tool for the
treatment of acute, subacute or even chronic peripheral
arterial thromboembolic occlusions. It can be used for short
or long occlusions with equal success, provided the
obstruction is not heavily calcified and has been safely
passed with a guidewire first.
Key words: Arteries/Femoral—arteries/Thrombosis—
thrombectomy
The treatment of acute and subacute thromboembolic and
local thrombotic ischemic lesions of the lower extremities
has undergone considerable changes over recent years. The
standard modality of surgical thrombectomy with the Fo-
garty balloon catheter technique for acute arterial occlusions
has been replaced by percutaneous catheter techniques at
many institutions. The simplest technique is percutaneous
aspiration thrombectomy (PAT) for thrombus aspiration [1,
2]. Alternatively catheter-directed pharmacologic thrombo-
lytic therapy with or without additional catheter aspiration is
used, particularly if the occlusion is already a few days or
weeks old [3, 4]. These techniques obtain the best results in
acute occlusions of less than 2 weeks duration [1].
Various mechanical devices have been introduced which
involve maceration or fragmentation and removal of
thrombus. There are two categories of devices for
mechanical thrombectomy (MT): (1) rotational recirculation
devices which work by the vortex principle, such as the
Amplatz thrombectomy catheter (ATD, Microvena, White
Bear Lake, MN) or the Arrow-Trerotola PTD (Arrow
International, Reading, PA); and (2) hydrodynamic (rheo-
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lytic) recirculation devices which operate on the principle of
the Venturi effect, such as the Hydrolyser (Cordis, Johnson
and Johnson, Miami, FL), Oasis (Boston Scientific, Galway,
Ireland), and the Angiojet (RTC; Possis Medical, Minne-
apolis, MN) [5–10]. These devices are not suited for sub-
acute occlusions of more than 7–14 days duration. Recently
a new rotational mechanical thrombectomy catheter, the
Straub Rotarex (Straub Medical, 7323 Wangs, Switzerland)
has been introduced in Europe. This device combines the
two essential effects of mechanical clot fragmentation and
removal of the fragmented clot material from the vessel by
negative pressure [11, 12].
The purpose of the following retrospective report from a
single center is to present the 1 year follow-up results after
recanalization of acute and subacute femoropopliteal
occlusions with the Rotarex catheter. To our knowledge this
study includes the largest number of patients treated pri-
marily with the Rotarex catheter for occlusions of the native
femoropopliteal arterial axis with a 12 month follow-up
including primary and secondary patency rate survival
curves.
Materials and Methods
The Rotarex Catheter and its Application
The Rotarex catheter consists of a coated stainless steel spiral
rotating inside an 8 Fr single-lumen tetrafluorethylene–hexafluor-
propylene copolymerizate (FEP) catheter. The tip of the catheter
consists of a dual-blade windowed cutting crown of which the
inner blade or stator is connected to the catheter shaft. The outer
blade or so-called rotor is connected to the rotating spiral which is
driven by a 40 W reusable electric motor unit. The spiral and motor
are connected before use by a magnetic clutch. The rotating spiral
running at 40,000 rpm creates a vacuum at the catheter tip and the
abraded fresh or organized occlusion material is sucked through
the cutting slits, fragmented, and transported by the rotating spiral
through the catheter lumen into a collecting bag (Fig. 1).
Since the Rotarex is an over-the-wire system (0.020 inch) any
occlusion needs first to be recanalized by conventional guidewire
technique. After assessment of the lesion by direct antegrade
angiography via a common femoral artery approach the occlusion
is recanalized with a Terumo J wire (0.035 inch) (Terumo, Som-
erset, NJ) and a 4 Fr angiographic catheter is placed across the
occlusion to allow the exchange for an 0.018 inch guidewire
(Boston Scientific). Afterwards, the device is introduced through
an 8 Fr hemostatic sheath and the catheter is activated while its tip
is still proximal to the occlusion to allow lubrication of the spiral
inside the catheter with the aspirated blood. Then the catheter is
slowly advanced into the occlusion in a to-and-fro motion with
occasional retraction into the already recanalized lumen (to allow
cooling of the catheter by the inflowing fresh blood) (Fig. 2). Care
must be taken to achieve sufficient cooling of the catheter tip and
evacuation of the debris to get an appropriate blood flow along the
catheter. In order to minimize peripheral embolization of clot the
distal end of the occlusion should not be passed too fast before all
loose material has been sucked back into the catheter. The device
allows reopening of approximately 10 cm of occlusion within 30–
60 sec. Several passages of the occlusion may be needed to clean
out all wall-adherent thrombotic material. If residual underlying
stenoses of >25% persist we use additional balloon angioplasty
and/or endovascular stents as needed (Fig. 2). In cases of periph-
eral embolization percutaneous catheter aspiration is our method of
choice.
As antithrombotic regimen we use 5000 IU of heparin intra-
operatively, followed by low-molecular-weight heparin therapy for
3–7 days and 100 mg of acetylsalicylic acid daily as long-term
treatment.
The catheter used in this study was designed for an antegrade
approach only. A new design for crossover application has been
introduced recently.
Patients
Forty-one limbs in 38 patients (17 men, 21 women; mean age
75.6 € 8.8 years, range 56–90 years) with occlusion of the fem-
oropopliteal axis were treated with mechanical thrombectomy
using the Rotarex system. The ischemic symptomatology was
graded according to the Fontaine classification; Rutherford cate-
gories are given in parentheses. One patient (2%) was Fontaine
stage IIa (Rutherford 1), 22 patients (54%) were stage IIb (Ruth-
erford 2–3), 14 patients (34%) were stage III (Rutherford 4), and 4
patients (10%) were stage IV (Rutherford 5–6).
Fig. 1. (A) Distal end/head of the Rotarex mechanical
thrombectomy device. (B) Schematic drawing showing the
functioning of the head of the Rotarex catheter. The fenes-
trated rotating dual blade (arrowhead in A and B) produces
cutting/grinding and aspiration of the clot material. The mo-
tor-driven coated spiral shaft (40,000 rpm; thin arrow in A
and B) running through the catheter causes suction (–435
mmHg) and removal of clot material.
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The age of the vascular occlusions varied between 1 and 180 days
with an average of 31.6 € 33.8 days. The stages of occlusion were
defined as follows: acute occlusion: £ 14 days old, subacute
occlusion 15–90 days old, and chronic occlusion more than 90 days
old. There were 16 acute occlusions (mean 8 € 4.8 days, range 1–14
days), 24 subacute occlusions (mean 41.1 € 21days, range 16–89
days), and 1 patient with a chronic occlusion 180 days old. In 2 cases
the duration of the occlusion could not be precisely dated but was
more than 2 weeks according to the clinical history. These 2 patients
have been included in the pool of the subacute lesions but have been
disregarded for the calculation of the mean lesion age. The occlu-
sions length varied between 2 and 35 cm, with a mean of 13.1 € 7.5
cm. Nineteen occlusions were £ 10 cm, 22 were >10 cm. The
localization of the occlusions along the femoropopliteal axis was as
follows: 26 occlusions were located in the proximal half of the
superficial femoral artery (SFA), 15 occlusions were located in the
distal half of the SFA including the proximal half of the popliteal
artery. There were no isolated occlusions of the popliteal artery.
The inclusion criteria were: (1) an occlusion situated in the
femoropopliteal axis with a patent distal popliteal artery and tri-
furcation; (2) successful passage of the occlusion with a guidewire
followed by Rotarex thrombectomy as the primary form of treat-
ment. Exclusion criteria were an occlusion of the distal popliteal
artery and trifurcation, the known presence of a popliteal aneu-
rysm, coagulopathy or a blood creatinine value of ‡ 300 lg/l, and
subintimal recanalization with the guidewire.
The pre-interventional evaluation consisted of the clinical sta-
tus, including an oscillographic examination at three levels (thigh,
leg, and great toe) and brachial–ankle index (BAI), as well as a
color duplex examination to evaluate the extent of the occlusion,
and the patency of the distal popliteal and tibial arteries.
The same protocol was used for follow-up at 48 hr, 3, 6, and 12
months after the intervention. The threshold of significant reste-
nosis was set at >50% as estimated on color Doppler flow mea-
surements [13].
Statistical Analysis
Quantitative data are expressed as mean values € 1 standard
deviation. The Kaplan–Meier method was used to calculate the
cumulative patency rates. The Wilcoxon rank signed test was used
to evaluate intraindividual differences of a variable before and after
treatment. The log rank test was used to compare Kaplan–Meier
survival curves. Statistical analysis was done with the SPSS sta-
tistical software (SSPS 12, Chicago, IL).
Definitions
Technical success was defined angiographically in the presence of
a final residual luminal stenosis of less than 25%. If this goal was
not reached with Rotarex treatment only, additional percutaneous
transluminal angioplasty (PTA) and/or stent-graft placement was
performed in the same session.
Primary patency was defined as an uninterrupted patency with
no procedures performed on or at the margins of the treated seg-
ment [14]. Secondary patency was defined as restoration of pa-
tency by means of any procedure after thrombosis or restenosis
[14].
Results
Technical Success
All treated limbs were recanalized with a markedly im-
proved lumen after an average of two passages (one to four)
Fig. 2A–D. An 84-year-old
patient with Fontaine stage III
symptomatology of the right
leg for 20 days. (A) Digital
subtraction angiography
(DSA) shows an occlusion of
the superficial femoral artery
(SFA). (B) DSA shows the
guidewire crossing the 20 cm
long occlusion. Note the head
of the Rotarex catheter
(arrow) in the common
femoral artery, directly before
the occlusion. (C) DSA after
two passages with the
Rotarex catheter (135 sec and
65sec) shows the recanalized
segment of the SFA. (D)
Angiography after additional
PTA.
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with the Rotarex device. The mean duration per passage was
42 € 31 sec (range 10–180 sec). During the intervention, an
average of 122 € 50.5 ml (range 50–200 ml) blood with
debris was aspirated into the collecting bag. All but 2 of 41
limbs (95%) had a residual stenosis of >25%. These patients
underwent additional PTA in the same session. Three pa-
tients were stented (Jostent, Jomed, Beringen, Switzerland;
Peiron Stent, Biotronic BLlach, Switzerland) for a dissection
after PTA, and one additional case was stented in order to
treat a stenosis distal to the recanalized segment. In one case
a Wallstent (Boston Scientific, Galway, Ireland) was placed
for a vessel perforation with a persistent leak after unsuc-
cessful prolonged balloon inflation. Two limbs were free of
stenosis after the passage of the Rotarex device alone, and
had no additional PTA. Thus a primary technical success of
100% was achieved.
Complications
The complications are listed in Table 1. Of the 21 (51%)
complications encountered only 2 (5%) were major. One
patient developed a large hematoma at the puncture site,
which required transfusion of 2 units of blood. In a second
patient an arteriovenous fistula at the level of the recanal-
ized segment spontaneously thrombosed after unsuccessful
primary prolonged balloon dilatation. The other complica-
tions were rated as minor following the criteria of the
SCVIR [14]. Three arterial perforations were successfully
sealed with prolonged balloon dilatation (5–10 min)
(Fig. 3). One of these showed formation of a pseudoaneu-
rysm at the site of previous perforation at the 3 months
follow-up examination; after placement of a stent-graft
(Jostent, Jomed, Beringen, Switzerland) successful occlu-
sion of the perforation was obtained. One perforation was
treated with placement a Wallstent (Boston Scientific,
Galway, Ireland) after unsuccessful prolonged balloon
inflation. The color duplex examination at 48 hr showed no
vascular leak through the meshes of the stent. In 10 of 41
(24%) thrombectomy procedures peripheral embolizations
were noted: 5 after Rotarex thrombectomy itself, and 5 after
additional PTA. Six that were clinically relevant were
treated by aspiration. Two of these required additional
thrombolysis with 80,000 IU and 100,000 IU of urokinase,
respectively. In one of these latter 2 patients an initially
unrecognized popliteal aneurysm had been recanalized.
Four clinically irrelevant embolisms were left untreated.
Four pseudoaneurysms detected at duplex ultrasound after 2
days at the puncture site were treated conservatively by
ultrasound-guided compression [2] or thrombosed sponta-
neously [2].
Clinical Success and Follow-up
Two patients presented with an early reocclusion within 24
hr. One patient was recanalized two times for acute reoc-
clusion with aspiration and PTA. Repeated treatment with
the Rotarex catheter was not possible due to the occlusion of
the entire SFA which precluded safe antegrade access of the
device. Because of subsequent reocclusion, a surgical by-
pass was performed 6 weeks later. The second patient
showed an early reocclusion 1 day following the initial
successful thrombectomy. The spontaneous amelioration of
the clinical symptoms rendered a surgical bypass unneces-
sary. One patient with early reocclusion at 8 and 13 days
was successfully treated with thrombolysis and catheter
aspiration. Due to the oral anticoagulation of the patient and
the formation of a pseudoaneurysm with a local hematoma
at the puncture site following the Rotarex procedure, the use
of a large 8 Fr introducer sheath had to be avoided. A further
patient with a stent in the SFA occluded 15 days after the
first Rotarex procedure. Repeat thrombectomy with the
Rotarex device, completed by catheter aspiration, ended in a
good final result. One patient benefited from an iliofemoral
surgical bypass 8 months after the recanalization for an
acute occlusion of the external iliac artery; the previously
recanalized segment (SFA) was still open at the time of
surgery.
At the 3 months follow-up control the rate of significant
restenosis was 23% (7/30), at the 6 months control it was
48% (13/27), and at 12 months control it was 39%(10/26).
Only 2 of all recurrences were complete occlusions. The
first was detected at the 6 months control and required a
surgical bypass operation. The second occlusion was diag-
nosed at the 12 months control and was successfully treated
with repeat thrombectomy with the Rotarex device.
The mean follow-up was 12 months (range 1 day to 51
months). The primary cumulative patency rate was 87% at 3
months, 62% at 6 months, and 39% at 12 months (Fig. 4).
The secondary patency rate was 95% at 3 months, 84% at 6
months, and 68% at 12 months (Fig. 5). No statistically
significant difference was found between the primary and
secondary patency rates of the entire patient pool compared
with subgroups defined according to occlusion length,
occlusion localization, and occlusion age.
The BAI, including in cases with reobstruction, was
significantly (p < 0.01) improved after thrombectomy,
rising from 0.41 before treatment to 0.92 immediately
after treatment and remaining at relatively steady values
of 0.93 at 3 months, 0.92 at 6 months, and 0.9 at 12
months.
Table 1. Complications during or following recanalization with the
Rotarex device
Major
complications
Minor
complications
Arteriovenous fistula 1
Significant hematoma 1
Vessel perforation 4
Peripheral embolization 10
Pseudoaneurysm following
vessel perforation
1
Pseudoaneurysm at puncture site 4
Numbers indicate the number of patients.
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Clinically, the Fontaine stages showed improvement of
the clinical symptoms. Before thrombectomy the majority
of patients (98%) were Fontaine stage IIb or above. At the
3 months control 97% of the patients were either stage I
(23) or IIa (6). This rate decreased slowly at 6 months
(81%) and 12 months (85%) (Fig. 6). Among the patients
who had a significant restenosis at follow-up the majority
were either asymptomatic or only slightly symptomatic,
with 86%, 73%, and 75% being Fontaine stages I–IIa at 3,
6, and 12 months, respectively. All the patients without
significant restenosis were Fontaine stage I–IIa at 3 and
12 months, while only 1 patient of 10 (10%) was stage IIb
at 6 months.
None of our patients underwent amputation in the 12
months follow-up. Only one patient needed a surgical by-
pass 6 weeks after the thrombectomy procedure due to re-
peated early reocclusions.
During the 12 months follow-up 6 patients died. The
mean age of these patients was 79 € 12 years. Their death
was neither directly nor indirectly related to the thrombec-
tomy procedure.
Discussion
Percutaneous catheter aspiration thrombo-embolectomy is
the simplest and most cost-effective mechanical way to treat
Fig. 3A–C. A 61-year-old patient
presenting with Fontaine stage IIb
ischemic symptomatology for 25
days. (A) Angiography shows a 10
cm long occlusion of the SFA. (B)
After two passages with the Rotarex
thrombectomy device a vessel
perforation is noted at the level of
the former occlusion. (C)
Angiography after prolonged
dilatation (two times 5 min) shows
sealing of the perforation with a
widely patent lumen of the SFA.
Fig. 4. Primary patency rate of 41 femoropopliteal arteries
after recanalization with the Rotarex mechanical thrombec-
tomy device.
Fig. 5. Secondary patency rate of 41 femoropopliteal
arteries after recanalization with the Rotarex mechanical
thrombectomy device.
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acute femoropopliteal occlusions. Acute popliteal emboli in
particular may be treated without any additional thrombol-
ysis or even the need for balloon dilatation if there is no
underlying or concomitant atherosclerotic lesion [2, 15].
However, since in native arteries there seems to be rapid
onset of thrombus organization thrombi start to become
adherent to the vascular wall within a couple of days, ren-
dering catheter aspiration without additional lysis difficult
or insufficient. In addition many occlusions are caused by an
underlying plaque and/or thrombus, so the ideal thrombec-
tomy device should also be capable of removing organized
thrombus [3, 16]. Data for MT using rotational recirculation
devices which work by the vortex principle or hydrody-
namic (rheolytic) recirculation devices report success rates
in the lower extremity arteries of 66–90% [1, 7–9, 17–19];
however, adjunctive thrombolysis (usually overnight) was
required in 20–42% of cases [1, 7–9, 17, 18]. Rousseau et al.
reported success for MT alone in 61% of their cases, which
was increased to 83% by adding thrombolytic therapy [1,
17]. Morgan and Belli [1] concluded that mechanical
thrombectomy devices are useful for the treatment of
thrombosed dialysis grafts but less effective in native
arteries and bypass grafts.
The Rotarex catheter was especially designed to ad-
dress removal of organized, solid thrombus, while the
possibility of plaque removal cannot be excluded [11]. Its
construction is relatively simple, with a rotating win-
dowed cutting head and only a single lumen for a coaxial
guidewire and a spiral which transports the aspirated
material through the catheter into a collecting bag. The
unique feature of this device consists of a radial expan-
sion coefficient of 2 in fresh and partly organized
thrombus, which means that a diameter of 2.6 mm (8 Fr)
clears a lumen of more than 5 mm [12]. It is feasible to
use this device in arteries with a diameter of 4–7 mm [11,
20]. To use the device once the occlusion has been
crossed with a guidewire is easy.
The technical and initial clinical results demonstrate
equal success in long and short acute and subacute
occlusions of the femoropopliteal artery. Therefore the
device seems very useful in clinical practice in cases
where a long procedure is not easily tolerated by the pa-
tient or in cases where the use of thrombolysis is contra-
indicated or carries an increases risk of bleeding
complications.
In our study, the technical success rate was 100%
(41/41). To optimize the immediate result after thrombec-
tomy with the Rotarex catheter (> 25% residual lumen
reduction, mostly due to underlying chronic plaque forma-
tion) PTA was performed in 95% of cases, with additional
stenting in 3 limbs because of a local dissection following
PTA and for a recoiling lesion distal to the initial obstruc-
tion in another case. Furthermore another patient benefited
from stent placement after unsuccessful prolonged balloon
inflation of an arterial perforation. Additional thrombolysis
was needed in only 2 patients (5%) in whom peripheral
emboli after thrombectomy could not be fully aspirated by
PTA. Thrombolysis was never used as an adjunctive mea-
sure for the primary recanalization procedure. Using the
same device BNrczi et al. [21] and Zeller et al. [20] reported
similar primary success rates of 94% and 96%, respectively.
Only in 2 patients was additional local thrombolysis used to
treat symptomatic perinterventional peripheral emboli [20],
while the rates for additional thrombolysis in mechanical
thrombectomy reported in the literature vary between 58%
and 100% [1, 3, 4, 7, 16, 20–23]. Mechanical maceration
[16, 20, 21] seems to give slightly better results than
hydrodynamic approaches [1, 3, 7, 22]. In some studies PTA
also showed high success rates in the range of 90–95% [1–4,
24]. However, additional thrombolysis was used in 71%
[24] and 22% [4] of cases, respectively. In the report by
Zehnder et al. [4] 87.5% of patients had acute onset of
occlusion less than 14 days old and no patient had an
occlusive episode of more than 4 weeks. In addition the
Fig. 6. Evolution of the Fontaine
stage for clinical classification of
limb ischemia before, and 3, 6, and
12 months after femoropopliteal
recanalization.
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history of acute symptoms in the patients who did not need
thrombolysis was only approximately 5 days. It should be
mentioned that many of the emboli treated with aspiration
were either due to PTA or thrombus residue after throm-
bolysis [10] After prolonged thrombolysis recanalization
rates vary between 79.7% and 85% for acute or subacute
occlusions [25, 26].
Periprocedural peripheral embolism occurred in 24% of
our cases (10/41), five times during thrombectomy with the
Rotarex and five times after subsequent dilatation, but no
clinically relevant sequelae occurred after additional cath-
eter aspiration or lysis. Zeller et al. [20] reported a much
lower rate (10%) of peripheral embolization and never
during the application of the Rotarex, but only after
additional angioplasty. Berczi et al. [21] had a cohort of
patients similar to ours, as regards age as well as Fontaine
stages, but also reported a lower rate of peripheral embolism
(18%). In 2 of the 3 cases, emboli occurred during recana-
lization with the Rotarex catheter and all were treated with
additional aspiration. However, according to our own
learning curve peripheral embolization can be markedly
reduced by slow advancement and multiple retractions of
the catheter back to the unoccluded segment in order to
clean out as much loosened material as possible before re-
establishing flow by crossing the most distal part of the
occlusion. The rate of peripheral embolization is similar in
other reports of mechanical thrombectomy, ranging usually
between 3% and 10%, but may be as low as 0 and as high as
28% [1, 22]. In many of these reports a high proportion of
patients were routinely treated with additional local
thrombolysis [22].
The complication rate (51%) in our study may appear
rather high, but apart from one large groin hematoma and an
arteriovenous fistula at the level of the recanalized segment
the complications were mostly of minor or no consequence
and could be treated by means of endovascular techniques
during the same procedure, such as aspiration of peripheral
emboli. None needed surgical treatment or amputation. Four
small pseudoaneurysms were picked up at the 1–2 days
duplex ultrasound control which otherwise might have not
been detected at all because of spontaneous closure. In our
experience the relatively large size of the catheter sheath (8
Fr) was not coupled with an increased risk of bleeding and
pseudoaneurysm formation at the puncture site compared
with alternative techniques such as catheter aspiration,
which also needs introducer sheaths of at least 8 Fr for the
femoropopliteal axis.
A potential complication which seems unique to the
Rotarex device is vessel wall perforation, which may even
lead to an arteriovenous fistula. We encountered four per-
forations, one pseudoaneurysm formation at the site of
previous perforation at the 3 months follow-up examination
and one perforation with a concurrent arteriovenous fistula.
This complication has also been reported in 2 of 19 treated
limbs by BNrczi et al. [21], and 3 of 31 (10%) femoropop-
liteal occlusions in the study by Zeller et al. [20] and were
treated in a similar fashion. As in our patients, these patients
had heavily calcified vessels. Presumably the rather sharp
edges of the rotating catheter tip may catch at a plaque,
thereby causing rupture of the vessel wall. Therefore care
should be taken and patients with significant calcifications
at the site of occlusion may be better not treated with this
device. To avoid embolizations a slow advancement and
repeated retraction of the catheter proximal to the occlusion
before crossing the most distal part of the occlusion is
essential.
In summary, apart from the above-mentioned vessel wall
perforation the complications are not specifically related to
this device and no different from those of other instruments,
though the incidence of hemorrhagic complications defi-
nitely seems lower than in techniques using additional
thrombolysis [3, 22, 25, 27].
The restenosis rates in our study are similar to those
published by Zeller et al. [16, 20], with rates of 33% and
37% at 6 and 12 months, respectively. Studies concerning
thrombolytic therapy, notably the STILE study [2], also
noted significant restenosis rates at 1 year, varying between
32% and 36%. The primary and secondary patency rates
tally with the data of Berczi et al. [21]. These authors de-
scribe primary patency rates of 39 € 13% at 6 and 12
months with steady patency rates of about 40% during 19
months follow-up and secondary patency rates of 53 € 13%.
In our experience the long-term primary patency was 21% at
15 months and 10% at 18.5 months. These results have to be
interpreted with caution due to the very small number of
patients .
In our hands the costs involved using the Rotarex cath-
eter are approximately one fifth higher than for thrombol-
ysis and catheter aspiration (1000 Euro vs. 800 Euro).
Although we did not record procedure time, from personal
experience using alternative techniques we feel that the
Rotarex procedure saves a considerable amount of time and
therefore is cost-effective.
In conclusion, the Rotarex mechanical thrombectomy
device is an efficient, quick, easy to handle, and safe tool for
the treatment of acute, subacute or even chronic peripheral
arterial thromboembolic occlusions. It can be used for short
or long occlusions with equal success provided the
obstruction is not heavily calcified and has been safely
passed with a guidewire first.
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